Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

End-of-day quote. End-of-day quote  - 05/04
3621.95 INR   +0.47%
05/04 PFIZER : Drug Companies Pony Up in Illegal Marketing Cases, But Crit..
04/29 GLAXOSMITHKLINE : Glaxo, Save The Children Get Positive Opinion On A..
04/27 EXTRA : GlaxoSmithKline Clarifies Guidance After "Encouraging" Start
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
04/28/2016 04/29/2016 05/02/2016 05/03/2016 05/04/2016 Date
3738.95(c) 3724(c) 3664(c) 3605(c) 3621.95(c) Last
5 557 4 364 8 228 5 190 7 801 Volume
-0.69% -0.40% -1.61% -1.61% +0.47% Change
More quotes
Financials ( INR)
Sales 2016 27 898 M
EBIT 2016 5 266 M
Net income 2016 4 365 M
Finance 2016 16 631 M
Yield 2016 1,57%
Sales 2017 31 929 M
EBIT 2017 7 145 M
Net income 2017 5 722 M
Finance 2017 17 210 M
Yield 2017 1,68%
P/E ratio 2016 72,39
P/E ratio 2017 54,27
EV / Sales 2016 10,4x
EV / Sales 2017 9,08x
Capitalization 307 277 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
05/25Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
05/04 PFIZER : Drug Companies Pony Up in Illegal Marketing Cases, But Critics Wonder i..
05/03 GLAXOSMITHKLINE : DRAP may approve icrease in prices of medicines
04/29 GLAXOSMITHKLINE : Glaxo, Save The Children Get Positive Opinion On Antiseptic Ge..
04/27 EXTRA : GlaxoSmithKline Clarifies Guidance After "Encouraging" Start
04/27 TOP NEWS : GlaxoSmithKline Clarifies Guidance After "Encouraging" Start
04/25 GLAXOSMITHKLINE : ViiV Extends Licence Agreement For Dolutegravir
04/18 GLAXOSMITHKLINE : Opens GBP56 Million Facility In Ware (UPDATE)
04/18 GLAXOSMITHKLINE : Opens GBP56 Million Manufacturing Facility In Ware
More news
Sector news : Pharmaceuticals - NEC
07:05a ASTRAZENECA : *berenberg cuts astrazeneca price target to 4950 pence - 'buy'
04:41a JOHNSON & JOHNSON : Concerns about baby powder safety after large jury verdicts
05/04DJGRAIN HIGHLIGHTS : Top Stories of the Day
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions